SCHEMBL2215439

SCHEMBL2215439

C[C@@H]1CN(c2cnc(-c3ccoc3)cc2C=O)C[C@H](C)O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MTOR P42345 2/20 0.38
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PIK3CA P42336 2/20 0.37
PIK3R1 P27986 1/20 0.37
MAPT P10636 2/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
ERN1 O75460 3/20 0.35
XIAP P98170 1/20 0.35
BIRC2 Q13490 1/20 0.35
PBRM1 Q86U86 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215831 0.84 KDM4E (0.40) ALDH1A1MTORKMT2ATDP1PIK3CA
SCHEMBL2215921 0.83 KDM4E (0.39) ALDH1A1KMT2ATDP1PIK3CAMAPT
SCHEMBL2212859 0.82 LRRK2 (0.39) KMT2ATDP1PIK3CAPIK3R1MAPT
SCHEMBL2213684 0.82 CYP2A6 (0.42) MTORKMT2ATDP1PIK3CAPIK3R1
SCHEMBL2213881 0.81 LRRK2 (0.43) PIK3CAPIK3R1ERN1GSK3B
SCHEMBL2213101 0.81 KMT2A (0.40) ALDH1A1MTORKMT2ATDP1PIK3CA
SCHEMBL2216321 0.80 LRRK2 (0.43) MTORKMT2ATDP1PIK3CAPIK3R1
SCHEMBL2212210 0.80 KDM4E (0.41) ALDH1A1HSD17B10MTORKMT2ATDP1
SCHEMBL2212554 0.78 ERN1 (0.41) ALDH1A1CYP1A2MTORKMT2APIK3CA
SCHEMBL2215681 0.78 KDM4E (0.39) ALDH1A1KMT2ATDP1PIK3CAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL ASTRAZENECA R&D (SE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL TBCA, TUBA1A, BROX ALDH1A1 246/4885CYP1A2 1316/4885ALOX15 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.